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Abstract.  Depending  on the target cells and culture 
conditions,  scatter factor/hepatocyte growth factor 
(SF/HGF) mediates  several distinct activities,  i.e.,  cell 
motility,  proliferation,  invasiveness,  tubular morpho- 
genesis,  angiogenesis,  or cytotoxicity.  A  small isoform 
of SF/HGF encoded by a  natural  splice variant,  which 
consists of the NH2-terminal  hairpin  structure  and the 
first two kringle  domains but not the protease homol- 
ogy region,  induces cell motility but not mitogenesis. 
Two types of SF/HGF receptors have recently been 
discovered in epithelial  cells,  the high affinity c-Met 
receptor tyrosine kinase,  and low affinity/high capacity 
binding  sites,  which are probably located on heparan 
sulfate proteoglycans.  In the present  study,  we have 
addressed the question whether the various biological 
activities of SF/HGF are transduced  into cells by a 
single type of receptor.  We have here examined 
MDCK epithelial  cells transfected with a  hybrid 
cDNA encoding the ligand binding domain of the 
nerve growth factor (NGF)  receptor and the 
membrane-spanning  and tyrosine kinase  domains  of 
the Met receptor.  We demonstrate  that all biological 
effects of SF/HGF upon epithelial  cells such as the in- 
duction of cell motility, proliferation,  invasiveness,  and 
tubular morphogenesis  can now be triggered by the ad- 
dition of NGE  Thus,  it is likely that all known biolog- 
ical signals of SF/HGF are transduced  through  the 
receptor tyrosine kinase  encoded by the c-Met pro- 
tooncogene. 
S 
CATTER factor/hepatocyte  growth  factor  (SF/HGF) ~ 
has several distinct effects on cells in culture: (a) it is a 
strong  mitogen  for  primary  hepatocytes  as  well  as 
other cell lines (Nakamura et al.,  1987; Gohda et al.,  1988; 
Zarnegar and Michalopoulos, 1989; Rubin et al.,  1991); (b) 
it was independently  identified as a motility and invasion- 
inducing factor for epithelial and endothelial cells (Stoker et 
al., 1987; Gherardi et al., 1989; Rosen et al., 1990; Weidner 
et al.,  1990,  1991; Bussolino et al.,  1992); (c) it has cyto- 
toxic and cytostatic effects on certain other cell lines (Higa- 
shio et al.,  1990; Tajima et al.,  1991;  Shiota et al.,  1992); 
and (d) it was found to be an inducer of epithelial tubulogen- 
esis  (Montesano  et  al.,  1991a,b).  In  vivo,  SF/HGF  thus 
could play a role in tissue regeneration,  tumor progression, 
and embryological processes, which generally require both 
cell motility and cell proliferation. 
The identity between SF and HGF was demonstrated by 
amino acid sequencing, by immunological methods, and by 
comparison of the biological activities (Gherardi and Stoker, 
1990;  Weidner  et  al.,  1990,  1991;  Furlong  et  al.,  1991; 
Konishi et al., 1991) as well as by cDNA cloning, by receptor 
binding studies, and by the fact that a single gene exists in 
the human  genome  (Weidner et al.,  1991;  Naldini  et al., 
1. Abbreviations  used in this paper:  NGE nerve growth factor; SF/HGE 
scatter factor/hepatocyte growth factor. 
1991a). The SF/HGF cDNA, recently isolated from several 
sources  such as placenta,  liver,  leukocytes,  or fibroblasts 
(Miyazawa et al.,  1989; Nakamura et al.,  1989; Seki et al., 
1990; Rubin et al.,  1991; Weidner et al.,  1991),  encodes a 
90-kD protein with sequence and overall structure similar to 
plasminogen and other enzymes involved in blood clotting 
and fibrinolysis. The primary translation product is an inac- 
tive precursor (Hartmann et al.,  1992; Lokker et al.,  1992) 
which is proteolytically processed into the active, disulfide- 
linked heterodimer.  The heavy chain consists of a hairpin 
structure and four kringle domains, the light chain exhibits 
sequence similarity to serine proteases. Due to the absence 
of important catalytic amino acid residues (e.g., the serine 
of the active site), this light chain has probably no protease 
activity. 
A high affinity receptor of SF/HGF (Kd •  0.2 nM) has 
recently been discovered in epithelial cells, the c-Met pro- 
tooncogene product  (Bottaro  et al.,  1991;  Naldini  et al., 
1991a,b). Met is a transmembrane receptor tyrosine kinase 
(Cooper et al.,  1984; Park et al.,  1987) made of a  145-kD 
/3- and a 50-kD a-subunit, which are synthesized as a single 
chain precursor (Giordano et al., 1989a,b). The a-chain and 
the NH2-terminal portion of the/~-chain are exposed on the 
cell surface, the COOH-terminal portion of the/~-chain is lo- 
cated in the cytoplasm and contains the tyrosine kinase do- 
main and phosphorylation sites involved in the regulation of 
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Naldini et al., 1991c). Isoforms of the Met receptor lacking 
the tyrosine kinase domain have recently also been described 
(Prat et al.,  1991; Komoda et al.,  1992).  SF/HGF binds 
specifically to the Met receptor, as demonstrated by copreci- 
pitation in immuncomplexes and by chemical crosslinking to 
the/~-subunit of the Met protein, and it induces rapid auto- 
phosphorylation of Met on tyrosine residues (Bottaro et al., 
1991; Naldini et al., 1991a,b; Hartmann et al., 1992). In ad- 
dition, low affinity/high capacity binding sites of SF/HGF 
(Kd 2-7 nM) are detected in binding experiments (Naldini 
et al.,  1991a; Komada et al.,  1992).  Since it is known that 
SF/HGF binds to heparin (Nakamura et al., 1987; Gohda et 
al., 1988; Zarnegar and Michalopoulos, 1989; Rosen et al., 
1989; Weidner et al., 1990),  it is likely that heparan sulfate 
proteoglycans of the extracellular matrix and the cell surface 
provide these additional binding sites. However, it was previ- 
ously not known which of the pleiotropic signals of SF/HGF 
are mediated into the cells by which of these receptors. 
A  further  interesting aspect  of the  action  of SF/HGF 
results from the analysis of mutant and variant SF/HGF iso- 
forms. We could recently show that the separately expressed 
heavy chain of SF/HGF as well as an isoform consisting of 
the NH2-terminal  hairpin structure and the first two kringle 
domains (Miyazawa et al.,  1991; Chan et al.,  1991), are 
sufficient to induce the motility but not the mitogenicity re- 
sponse (Hartmann et al.,  1992). 
In the present investigation we have addressed the question 
which of the SF/HGF receptors are responsible for the trans- 
mission of the diverse biological responses.  For this pur- 
pose, we have introduced into epithelial cells a eDNA ex- 
pression vector encoding a hybrid tyrosine kinase receptor 
which consists of the membrane spanning and cytoplasmic 
domains of Met fused to the extracellular domain of the 
nerve growth factor (NGF) receptor (trk). It has previously 
been shown that the extracellular domains of such hybrid 
receptors provide the ligand specificity, whereas the tyrosine 
kinase domain is responsible for the signalling specificity 
(Riedel et al.,  1989; Berhanu et al.,  1990).  We then asked 
which of the biological activities normally induced by SF/ 
HGF could now be observed in response to NGE 
Materials and Methods 
Cytokines and Cell Lines 
Recombinant SF/HGF was produced by cloning the SF/HGF eDNA (Weid- 
net et al.,  1991) into the pBlue Bac vector followed by expression in SD 
insect cells using the Maxbac baculovirus system (Invitrogen, San Diego, 
CA).  A  one-step purification  on  Heparin  Sepharose  resulted  in  pure 
SF/HGF with a specific activity of 5 scattering units per nanogram protein 
(cf.,  Weidner et  al.,  1990).  Purified NGF  (2.5S)  was purchased from 
Boehringer Mannheim GmbH (Maunheim, Germany) and I~I-NGF from 
Amersham Buchler GmbH (Braunschweig, Germany). The origin and cul- 
ture of the MDCK epithelial cell line (MDCK-2) is described in Behrens 
et al. (1989). 
Construction and Expression of the NGF 
Receptor-Met Hybrid cDNA 
The trk eDNA (encoding the human NGF receptor, plasmid LM6) was a 
kind gift of Dr. L. Parada (Fnxierick, MD). The mouse Met eDNA was 
isolated from a mouse liver eDNA library (ML 1035b; Clontech, Palo Alto, 
CA) using human Met eDNA as a probe (a kind gift of Dr. G. Vande Woude, 
Frederick, MD). Sequencing of our isolate revealed identity to the previ- 
ously characterized mouse eDNA (Iyer et al.,  1990;  Chan et al.,  1988). 
The eDNA  fragments for the construction of the hybrid receptor were 
generated by restriction digest and PCR amplification using standard tech- 
niques (Sarnbrook et al., 1989): Fragment I encoding the ¢xtracellular por- 
tion oftrk by EcoRI-BamHI digest (nucleotides -120 to 681); fragment II 
encoding the extracellular portion oftrk by PCR resulting in a BamHI-XbaI 
fragment (nuclcotides 682 to 1220);  fragment HI encoding the membrane- 
spanning and cytoplasmic portion of Met by Alwl-NotI digest (nuclcotides 
2787  to 4452).  Nucleotides are numbered from the translation start site 
(Martin-Zanca, 1989; Iyer et al., 1990). The FCR reaction to generate frag- 
ment II was performed on plasmid LM6 using the primers 5'-GGTCCA- 
GGTGCCCAATGCCTCGG and 5"AGCTGCTCTAGATCGTCCTTCTTC- 
TCCACCGG and Vent DNA polymerase (Biolabs, Beverly,  MA). After 
ligation of fragment I and II with T4 DNA ligase (Biolabs), fragment HI 
was introduced after removing the 5' protruding ends of the XbaI and AlwI 
sites by Mung Bean nucleasc (Stratagene, La Jolla, CA). The correct se- 
quence of fragment II and the resulting hybrid eDNA was confirmed by se- 
quencing using T7 DNA polymerase (Pharmacia Fine Chemicals, Piscata- 
way, NJ). The hybrid receptor eDNA was introduced into the SalI site of 
the pBAT expression vector (Nagafuchi and Takeichi,  1988).  Transfection 
of the hybrid receptor into MDCK epithelial cells was carried out using the 
calcium phosphate coprecipitation method of Graham  and van der Eb 
(1973).  In brief, 5  x  10  s MDCK cells were transfected with 10 ~g trk-Met 
construct and 1 ~g pSV2-neo. After culture in neomycin selective medium 
(0.8 mg/mi G418/DMEM/10% FCS), resistant colonies were analyzed for 
their sensitivity towards NGF and expression of the introduced eDNA. 
RNA Preparat/on, Northern Blotting, and 
Binding Assays 
RNA was prepared according to Chomczynski and Sacchi (1987).  12/zg to- 
tal RNA was glyoxylated and separated on a  1% agarose gel, transferred 
to Hybond-N membranes (Amersham Buchler GmbH) and hybridized with 
random-primed 32p-labeled  eDNA probes as described (Weidner et al., 
1991).  The  last two washing steps were with 0.5x  standard  saline ci- 
trate/0.1%  SDS at 62°C for 15-min each. Filters were subjected to autoradi- 
ography overnight at  -70°C. 
Specific cell surface binding of 125I-NGF (2.5S, 2,000 Ci/mmol) was 
analyzed according to Klein et al. (1991) and Cordon-Cardo et al. (1991). 
In brief, 10  s cells were incubated for 2 h at 4°C with 5 ng/ml IzSI-NGF in 
DME, 0.1% BSA in the presence or absence of a  100-fold excess of unla- 
beled NGE Cells were washed five times in DME, 0.1% BSA, lysed in 1 M 
NaOH, and radioactivity was measured in a 3,-counter. 
Assays for Cell Motility, Matrix Invasion, 
Morphogenesis,  and Growth Stimulation 
Dissociation and cell motility was examined in the MDCK colony dissocia- 
tion assay (Stoker et al., 1987; Weidner et al., 1990) in the presence or ab- 
sence of the indicated concentrations of SF/HGF or NGE Matrix invasion 
was examined as described previously (Behrens et al., 1989; Weidner et al., 
1990),  except that collagen was purchased from Seromed (Collagen G; 
Heidelberg, Germany). Invasive cells were counted after 3 d of culture by 
light microscopy. Tubule formation of MDCK cells was analyzed as de- 
scribed by Montesano et al. (1991a).  In brief, MDCK cells were cultured 
within collagen gels until cyst formation occurred, and then exposed to 
SF/HGF or NGF for different time periods. Growth stimulation by SF/HGF 
and NGF was investigated on MDCK cells cultured between two layers of 
collagen matrices. 5  x  104 MDCK cells were plated on collagen gels in 
six-well plates (Nunc,  Roskilde, Denmark) and overlayed with a  second 
layer of collagen matrix. After incubation for 1 d in DME-10% FCS, the 
cells were further cultured in the presence or absence of SF/HGF or NGE 
Growth was measured by counting cells in representative areas. 
Metabolic Labeling, Immunoprecipitation, and 
Western Blotting 
MDCK cells were labeled overnight with 0.2 mCi/ml [35S]cysteine (Amer- 
sham Buchler GmbH) in cysteine-free DME-10% FCS, washed with PBS, 
and extracted for 20 rain at 4°C with RIPA-kinase lysis buffer (50 mM 
Hepes, pH 7.2,  10 mM EDTA, 0.1% SDS, 1% NP-40, 0.5% deoxycholate, 
50 mM Na-pyrophosphate, 100 mM Na-fluoride, 2 mM Na-orthovanadate, 
30 mM phenylphosphate, 1 mM Zn-chloride, 50/~M ammonium molyb- 
date, 35/zM phenyl arsine oxide, 1.25 mM PMSF, 10/~g/ml aprotinin, 50 
/~g/ml leupeptin). After clearing by ultracentrifugation at 100,000 g, immu- 
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rum directed against the COOH terminus of mouse Met (Iyer et al., 1990; 
a generous  gift of Dr. G. Vande  Woude, Frederick)  and protein  A-Sepharose 
(Pharmacia Fine Chemicals). For competition, the immunizing peptide 
sp260 (10 #g/nil) was used. After washing in RIPA-kinase  lysis buffer  and 
high-salt buffer  (50 mM Hepes, pH 7.2, 0.5 M Li-chloride, 10 mM EDTA, 
L25  mM PMSF, t0  #g/ml aprotinin, 2  mM orthovanadate), the  im- 
munoprecipitates were solubilized in boiling SDS-sample  buffer  and elec- 
trophoresed under non-reducing  conditions on a 7.5 % SDS-polyacrylamide 
gel, followed by fluorography  at -70°C (el. Iyer et al., 1990; Naldini et 
al.,  1991a). 
For examining tyrosine autophosphorylation  of the NGF receptor-Met 
hybrid, MDCK  transfeetants  were  incubated for 30 rain at 37"C in the pres- 
ence or absence  of I00 ng/ml NGF in DME, 0.5% BSA, 7 #M phenyl  arsine 
oxide. After lysis  of the cells, immunopreeipitation  with anti-Met  antibody, 
and SDS gel electrophoresis  as described above, the proteins were trans- 
ferred onto Nitrocellulose membranes (Millipore Corp., Bedford, MA), 
probed with an anti-phosphotyrosine mAb (UBI, Lake Placid, NY), and 
stained using the enhanced chemiluminescence  system  (ECL, Amersham, 
Braunschweig). 
Results 
Construction and Expression of a NGF Receptor 
(trk)-Met Hybrid 7),rosine Kinase 
The eDNA encoding the extracellular domain of the human 
high affinity NGF receptor (trk; Martin-Zanca et al.,  1989; 
Kaplan et al., 1991) was fused to the sequence coding for the 
transmembrane and cytoplasmic regions of mouse Met (Fig. 
1). The chosen fusion point is located exactly at the outside 
border of the transmembrane domain. The resulting hybrid 
receptor (NGFR-Met) thus consists of the ligand-binding do- 
main  of  the  NGF  receptor  containing  characteristically 
spaced cysteinyl residues (Martin-Zanca et al.,  1989).  The 
cytoplasmic portion of the hybrid receptor consists of the 
tyrosine kinase domain of Met which  should confer Met- 
,F!  .... 
...  Val  Glu  Lys  Lys  ABp  Glu  ~nr  Pro  Pha  glv  Val  gar 
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Figure 1.  Schematic  structure  of the NGF receptor-Met hybrid. 
The extraceUular domain of the human NGF receptor (trk) is fused 
to the transmembrane and cytoplasmic domains of the mouse Met 
(marked are the cysteinyl residues of trk; Tk, tyrosine kinase do- 
main of Met). Nucleotide and amino acid sequences of the fusion 
point at the outside border of the transmembrane region are shown 
below (underlined, sequences of the transmembrane region; NGFR, 
human NGF receptor; Met, mouse Met; NGFR-Met, receptor hy- 
brid).  The cloning strategy resulted in one conserved amino acid 
change at the last position of the NGF receptor sequence, i.e., Glu 
to Asp. 
specific downstream signalling. The hybrid receptor cDNA 
in pBAT was cotransfected with pSV2-neo into MDCK epi- 
thelial cells, and subclones which have integrated the foreign 
DNA were selected for by G418. 
The NGF Receptor-Met Hybrid Tyrosine Kinase 
Confers NGF-mediated Dissociation and Motility 
Response in MDCK Epithelial Cells 
G418-resistant MDCK colonies were expanded and tested 
functionally for their ability to respond with cell dissociation 
toward the new ligand NGF. In fact, five out of 24 clones dis- 
sociated at NGF concentrations between  10 and 30 ng/ml 
(see example in Fig. 2, b and c; compare to control without 
NGF in a). Parental MDCK cells and control cells contain- 
ing only pSV2-neo showed no dissociation or morphological 
shape changes caused by NGE even at high NGF concentra- 
tions (Fig.  2 d). 
The NGF Receptor-Met Hybrid 7)~osine Kinase 
Is Expressed and Properly Located in the Plasma 
Membrane of the MDCK Transfectants 
RNA from the NGF-responding subclones was analyzed by 
Northern blotting for the expression of the trk-Met hybrid. 
In all transfectants which were sensitive to NGF in the dis- 
sociation assay, we detected a new mRNA species with the 
expected size of 4.5 kb, which hybridized with both a human 
trk probe coding for the extraeellular portion of the NGF 
receptor (Fig. 3, left filter, lanes a-d) and a mouse Met probe 
coding for the membrane-spanning and cytoplasmic region 
(Fig. 3, right filter, lanes a-d). Control MDCK cells did not 
express NGF receptor transcripts (Fig.  3, left filter, lane e 
and f).  However, we could detect endogenous Met in all 
MDCK clones tested (Fig. 3, right filter, lanes a-f). Approx- 
imately equal amounts of hybrid receptor and endogenous 
Met mRNA  were  observed in  the  NGF-sensitive  MDCK 
clones.  The  proper  cellular  location  of the  NGF  recep- 
tor-Met hybrid in the transfected MDCK cells was examined 
by cell  surface binding  experiments using  ]25I-NGE  Spe- 
cific binding to the NGF receptor-Met transfectants could in 
fact be measured (Fig. 4), which was competed for by an ex- 
cess of unlabeled ligand.  No specific binding was seen on 
control MDCK ceils containing only the pSV2-neo plasmid. 
These combined results  indicate that the introduced NGF 
receptor-Met hybrid is properly expressed and inserted into 
the plasma membrane of MDCK cells and forms a functional 
transmembrane receptor. 
The trk-Met Hybrid Receptor is Phosphorylated on 
1)/rosine Residues in Response to NGF 
An antibody directed  against the  COOH-terminus of Met 
was used to immunoprecipitate the trk-Met hybrid receptor. 
A new protein with a mol wt of 140 kD was in fact detected 
in metabolically labeled, NGF-sensitive MDCK cells (Fig. 
5 A,  lanes a  and b,  see arrow).  Control MDCK cells ex- 
pressed only endogenous Met with a mol wt of 190 kD (ar- 
rowhead in Fig. 5 A, lane c). Immunoprecipitation of both 
the hybrid receptor and Met was prevented in the presence 
of competing peptide (Fig. 5 A, lanes d-f, see also Materials 
and Methods).  Tyrosine autophosphorylation of the hybrid 
receptor was examined in transfected MDCK cells which 
were treated with and without NGE The addition of the new 
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transfected  MDCK  cells are 
dissociated in  a  dose-depen- 
dent manner by NGE (a) No 
factor, (b) 10 ng/ml NGF, and 
(c) 30 ng/ml NGE pSV2-neo 
control  transfectants  are  not 
affected by NGF even at high 
concentrations (d,  100 ng/ml 
NGF). Bar,  100 #m. 
Figure  3.  Detection of NGF 
receptor  (trk)-Met  hybrid 
mRNA  in  MDCK  transfec- 
tants  by  Northern  blotting. 
(a-d) The specific trk-Met hy- 
brid  transcript  (4.5  kb)  was 
detected with a trk probe (left 
filter) and a Met probe (right 
filter)  in  the  NGF-sensitive 
trk-Met transfectants 7, 2, 18, 
and 3; (e and f) represent rico 
control transfectants l  and 2. 
The Met probe also detected 
endogenous Met in all MDCK 
cell clones. RNA loading was 
verified  by  hybridization  of 
the  filters with a  32p-labeled 
actin probe. 
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Figure 4. Expression of trk-Met hybrid receptor on the surface of 
MDCK cell clones  confers  specific NGF binding.  Binding of 5 
ng/ml J25I-NGF was measured in the absence (n) or presence ([]) 
of  500 ng/ml unlabeled NGF. No specific binding was seen on con- 
trol cells (neo 2). Mean values of  triplicate samples of  two indepen- 
dent experiments are given. 
ligand  strongly  increased  tyrosine phosphorylation of the 
140-kD hybrid protein, as revealed by Western blotting of 
immunoprecipitates using  anti-phosphotyrosine  antibodies 
(arrow in Fig. 5 B, lanes a  and c, compare with the control 
in the absence of NGF, lanes b and d). Control transfectants 
did  not  show  any specific labeling  of the  140-kD  protein 
(Fig. 5 B, lanes e and f). The endogenous 190-kD Met was 
not transphosphorylated in response to NGF (Fig. 5 B); vice 
versa,  stimulation of the trk-Met transfected MDCK cells 
with SF/HGF resulted in strong autophosphorylation of the 
190- but not the  140-kD protein (data not shown, cf., also 
Hartmann et al.,  1992). Thus, binding of the NGF to the ex- 
tracellular portion of  the trk-Met hybrid receptor leads to the 
activation of the chimeric Met tyrosine kinase. 
The trk-Met Hybrid Mediates NGF-dependent 
Invasiveness and Tubulogenesis of MDCK Epithelial 
Cells in Collagen Gels 
When MDCK epithelial cells are plated on top of collagen 
gels,  SF/HGF induces invasiveness of single cells into the 
gel matrix (Weidner et al.,  1990,  1991).  Depending on the 
plating density, up to 10% of the cells can thus be forced to 
enter the gel within 2-3 d. We show here that MDCK clones 
expressing the  NGF receptor-Met  hybrid invade collagen 
gels in response to NGF (Fig. 6). The overall sensitivity of 
these cells toward NGF and SF/HGF was similar. The con- 
trol clones containing pSV2-neo were only sensitive to SF/ 
HGF but not to NGE 
When  SF/HGF is added to MDCK epithelial  cells pre- 
grown as cysts in collagen gels, the factor induces the out- 
growth  of tubules  within  a  few  days  (Montesano  et  al., 
1991a,b). Similar outgrowth of tubular networks is produced 
by NGF in MDCK cells expressing the NGF receptor-Met 
hybrid.  This process appears to occur in two steps; within 
the first 1-2 d, mainly single cells and small cell groups move 
away from the cysts (Fig. 7 c; compare to the control without 
NGF in a.  After 2-5  d,  however, the  invading cells form 
cords of tubular structures (Fig. 7 e). The responsiveness of 
the transfected cells toward NGF and SF/HGF was similar 
(Fig. 7, d and f); control clones containing pSV2-neo were 
insensitive toward NGF (Fig.  7  b). 
Figure 5. The 140 kD trk-Met 
hybrid receptor is phosphory- 
lated  on tyrosine  residues  in 
response  to  NGE  (A)  pS]- 
cysteine-labeled  MDCK clones 
expressing trk-Met (a and d, 
trk-Met 2; b and e, trk-Met 18) 
and  a  clone  expressing  only 
the neo resistance gene (c and 
f) were lysed and immunopre- 
cipitated by an anti-Met poly- 
clonal antibody in the absence 
(a-c)  and  presence  (d-f)  of 
competing peptide. The arrow 
marks the hybrid receptor at 
140 kD, the  arrowhead  indi- 
cates  the  endogenous  Met at 
190  kD.  (B)  MDCK  clones 
expressing the trk-Met hybrid 
(a and b, trk-Met 2; c and d, 
trk-Met  18) and a clone con- 
taining pSV2-neo only (e and 
f) were stimulated in the pres- 
ence (a, c and e) and absence (b, 
d, and f) of NGF (100 ng/ml). 
The hybrid receptor was immunoprecipitated with anti-Met antibody followed by Western blotting using an anti-phosphotyrosine antibody. 
The arrow marks the tyrosine-phosphorylated  140-kD hybrid receptor. 
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Figure 6.  NGF induces inva- 
siveness  of  trk-Met trans- 
fected MDCK cells into colla- 
gen matrices. NGF (I00 ng/ml, 
black bars) and SF/HGF (100 
ng/ml, hatched bars) strongly 
induced invasion of the trk- 
Met-expressing MDCK clones, 
whereas pSV2-neo clones only 
responded to SF/HGE With- 
out addition of  factors no inva- 
sion was measured (control). 
The NGF Receptor-Met Hybrid Mediates 
NGF-dependent Growth Stimulation 
In the course of this study we observed that parent MDCK 
cells proliferate slowly when cultured within collagen ma- 
trices  (Fig.  8,  and  data  not  shown);  in  the  presence  of 
SF/HGE however,  we found strong growth promotion. A 
similar growth-stimulatory effect is also inducible by the ad- 
dition of NGF to transfectants expressing the NGF recep- 
tor-Met hybrid (Fig.  8),  whereas control clones were not 
sensitive to NGE 
These combined results using MDCK epithelial cells ex- 
pressing  the  hybrid  NGF  receptor-Met  tyrosine  kinase 
clearly demonstrate that Met is the key component to trans- 
mit the SF/HGF signals into epithelial cells and to elicit the 
pleiotropic biological effects.  The  responses  mediated by 
Met thus include cell dissociation and shape change toward 
a fibroblastoid morphology, the motility response, the inva- 
siveness into extracellular matrices, and the morphogenic 
(tubulogenic) action as well as the growth-promoting activity 
in collagen gels. 
Discussion 
The motility/growth factor SF/HGF induces a variety of bio- 
logical responses in different cell types (cf., Nakamura et 
al.,  1989;  Rosen et al.,  1990;  Weidner et al.,  1990, 1991; 
Rubin et al.,  1991; Montesano et al.,  1991b; Shiota et al., 
1992;  Bussolino et al.,  1992),  and there exist at least two 
types of SF/HGF receptors in epithelial cells (Naldini et al., 
1991a): the high affinity Met receptor and low affinity/high 
capacity binding sites.  Since SF/HGF is known to bind to 
heparin, these low affinity binding sites are likely confined 
to  heparan  sulfate proteoglycans.  Although  it  has  been 
demonstrated that binding of SF/HGF to  epithelial cells 
results in the autophosphorylation of tyrosine residues of the 
Met receptor (Bottaro et al.,  1991; Naldini et al., 1991a,b; 
Hartmann et al., 1992), it was previously not known which 
of the biological signals, if any, are mediated by which of the 
known SF/HGF receptors.  Furthermore, heavy chain iso- 
forms of SF/HGF produced only the motility but not the 
mitogenicity response (Hartmann et al.,  1992),  suggesting 
the participation of different types of receptors in motogenic 
and mitogenic signal transduction. In the present investiga- 
tion we could clearly show,  by examining a hybrid NGF 
receptor-Met  tyrosine kinase in MDCK epithelial cells, that 
cell dissociation and motility response,  induction of inva- 
siveness and tubulogenesis, and growth stimulatory effects 
are mediated specifically through the hybrid Met tyrosine ki- 
nase. Thus, it is likely that all known biological responses 
of SF/HGF are actually transduced by the Met receptor, 
while the role of  the low affinity  binding sites is presently un- 
known. 
The question whether signal transduction through the Met 
receptor is sufficient to transduce the pleiotropic effects of 
SF/HGF could here not be addressed by simply expressing 
the Met eDNA in Met-negative  cells.  For instance, fibro- 
blasts which do not express significant levels of Met, often 
produce the ligand and they are motile without stimulation: 
epithelial cells which are main targets for SF/HGF, express 
both high and low affinity receptors. In contrast, the chosen 
approach of expressing a hybrid NGF receptor-Met kinase 
in epithelial cells was ideally suited to address our question: 
(a) High affinity NGF receptors (the trigs) are not expressed 
in epithelial cells (Klein et al.,  1990;  Martin-Zanca et al., 
1990); (b) Low affinity NGF receptors (p75; Johnson et al., 
1986;  Radecke et al.,  1987) could also not be detected on 
MDCK cells; and (c) In contrast to SF/HGF, NGF does not 
bind to heparin. Thus, in the used experimental system nei- 
ther heparan sulfate proteoglycan binding sites nor other en- 
dogenous receptors interfere with the action of NGF via the 
hybrid receptor. Furthermore, MDCK epithelial cells could 
here be used for the transfection with the hybrid receptor 
eDNA, and these cells show a wide variety of biological re- 
sponses to SF/HGE 
The MDCK cells transfected with the NGF receptor-Met 
hybrid cDNA  expressed  a  novel 4.5-kb  mRNA  species, 
which hybridized to both trk and Met sequences. The newly 
generated 140-kD hybrid protein could he immunoprecipi- 
tated with anti-Met antibodies and was found to be properly 
located in the plasma membrane, as shown by NGF surface 
binding. Furthermore, the 140-kD hybrid receptor was au- 
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thelial morphogen for trk-Met 
transfected  MDCK  cells. 
MDCK  cells  expressing  the 
hybrid  receptor  and  control 
MDCK cells  were grown for 
two weeks in collagen gels un- 
til the formation of large cysts 
was observed. The addition of 
NGF (200 ng/ml)  for one (c) 
or 5  d  (e),  or SF/HGF  (200 
ng/ml) for one (d) or 5 d (f), 
resulted  in the  outgrowth of 
single cells and the formation 
of a tubular network.  (a) No 
factor added,  (b) neo control 
clone, 5 d after the addition of 
200 ng/ml NGE Bars: (a-d) 
100 #m; (e and f) 250 t*m. 
tophosphorylated on tyrosine residues in response to NGE 
Thus, the MDCK cells expressing the trk-Met hybrid recep- 
tor met all formal requirements  for mediating NGF signals 
via the Met tyrosine kinase.  Remarkably,  the  MDCK cell 
clones which were initially  selected  to show the  NGF re- 
sponse in the dissociation assay, were also sensitive,  at the 
expected  concentrations  of  ligand,  in  the  invasion  and 
tubulogenesis  assays  as  well  as  in  the  newly  developed 
growth assay. This indicates that one type of hybrid receptor 
population, for which we have selected by one particular as- 
say, also transmits  the other biological signals. 
We have previously found that SF/HGF induces invasive- 
ness of various epithelial cells when these are plated on the 
top of collagen gels (Weidner et al.,  1990,  1991). It was sug- 
gested that this process resembles the progression of carci- 
noma cells to a more malignant stage in vivo. Montesano et 
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Figure  8.  NGF  stimulates 
proliferation  of  trk-Met  ex- 
pressing  MDCK  cells.  The 
cells were plated between two 
layers  of collagen  gels and 
were further cultured in 200 
ng/ml NGF  (o),  200  ng/ml 
SF/HGF  (e),  or  no  factor 
(*).  Cell numbers were de- 
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al. (1991a,b) have recently reported that precultured cysts of 
MDCK cells in collagen gels form tubular structures follow- 
ing the addition of SF/HGE It was suggested that this process 
resembles the outgrowth of kidney tubules during embryonal 
morphogenesis. How can the invasiveness of (mainly single) 
cells be reconciled with the outgrowth of tubules? When we 
here  examined  MDCK  cells  expressing  the  NGF  recep- 
tor-Met hybrid in collagen gels, we could clearly identify 
two stages of outgrowth (Fig. 7). In a first wave, mainly sin- 
gle cells migrated away from the cysts, while at later stages 
the formation and outgrowth of tubules was observed. This 
two-stage behavior was also seen when the outgrowth was in- 
duced by SF/HGE Thus, our data suggest that invasiveness 
and tubulogenesis (at least in its  initial phase) occur by a 
similar mechanism. 
Previously, we did not assay for proliferation signals in the 
case of MDCK ceils, since these cells are difficult to growth- 
arrest in conventional tissue culture. However, when MDCK 
cells were here cultured between sheets of collagen gels, we 
observed clear inhibition of proliferation, which could be 
overcome by the addition of SF/HGE  Proliferation could 
also be triggered with NGF in the MDCK cells expressing 
the NGF receptor-Met tyrosine kinase. Similarly, growth of 
MDCK cells in soft agar was stimulated by SF/HGF (Uehara 
and Kitamura,  1992).  This clearly indicates that motility, 
morphogenic, and growth responses of MDCK cells toward 
SF/HGF are transduced by the activation of a single recep- 
tor,  Met.  It is  obvious that the  cytotoxic and  angiogenic 
effects of SF/HGF (as seen in other cell types) could not be 
tested with our transfected MDCK cells and thus, the ques- 
tion whether these biological responses to SF/HGF are also 
transduced through Met will require further studies. 
The motility/growth factor SF/HGF has a unique structure 
which has not been observed in other motility or growth fac- 
tors (for the case of thrombin see Vu et al.,  1991). SF/HGF 
is similar in its amino  1  acid sequence to proteases involved 
in fibrinolysis or blood coagulation. In these proteins, the 
kringle domains and other modules contained within one 
subunit bind to specific protein sites,  whereas the second 
subunit, the serine protease, then cleaves selected substrates 
(Van Zonneveld et al.,  1986; Roldan et al.,  1990). We have 
recently shown that a  naturally occurring isoform of SF/ 
HGF consisting of only the NH2-terminal region and the 
first two kringle domains of the heavy chain is able to bind 
the Met receptor and to trigger the motility but not the mito- 
genic response (Hartmann et al.,  1992). The function of the 
light  chain  of  SF/HGF,  which  does  not  seem  to  exert 
proteolytic activity, is presently unknown.  However, since 
the whole heterodimeric molecule seems to be required for 
the generation of a full mitogenic response, the light chain 
may participate in this activity. Our present data now indi- 
cate that the various isoforms of SF/HGF mediate motility 
and/or growth signals through a single receptor, Met.  The 
detailed mechanisms of signalling leading to the different 
types of cellular responses are not yet known. It is interest- 
ing, however, that in the case of the related FGF receptor, 
a  point mutation in the tyrosine kinase domain abolished 
phosphatidylinositol turnover but not mitogenesis (Peters et 
al.,  1992; Mohammadi et al.,  1992). The present data also 
suggest that the low afffinity/high  capacity binding sites of 
SF/HGF on epithelial cells are not directly involved in signal 
transduction. These low affinity binding sites might still play 
an important role in the storage of the factor in the extracel- 
lular matrix or in its presentation to the Met receptor. Such 
a role for heparan sulfate proteoglycans has recently been 
demonstrated for the FGF receptor system (Yayon et al., 
1991; Rapraeger et al.,  1991). 
Coordinated  movement,  growth,  and  differentiation of 
cells are essential prerequisites for embryonal development 
and tissue regeneration in vivo. A reoccurring picture in de- 
velopment is that certain groups of cells influence motility, 
growth, and differentiation of other cells in their vicinity. In 
particular, exchange of signals between epithelial and mesen- 
chymal cell compartments are major driving forces in devel- 
opment (cf., Ekblom, 1989; Gumbiner, 1992, for reviews). 
Recently, several receptor tyrosine kinases expressed in epi- 
thelia and their mesenchymally derived ligands have been 
implicated in these mesenchymal-epithelial interactions (cf., 
Stern et al.,  1990; Montesano et al.,  1991a,b; Sonnenberg 
et al.,  1991;  Sonnenberg et al.,  1993;  Wen et al.,  1992; 
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tor/ligand systems possibly involved in mesenchymal-epithe- 
lial interactions is SF/HGF/c-Met.  Studies of SF/HGF and 
Met expression in cell culture show that the ligand is gener- 
ally not produced by the same cells which respond to it and 
which express the receptor (Stoker et al., 1987; Weidner et 
al., 1991; Naldini et al., 1991a). Furthermore, during mouse 
embryogenesis the ceils expressing SF/HGF are also differ- 
ent but often in close vicinity to cells which transcribe the 
c-Met gene, suggesting a paracrine mode of action in vivo as 
well. For example, during kidney development c-Met is ex- 
pressed in the epithelia of the ureter buds and of  the proximal 
and distal tubules; transcripts for SF/HGF are found in the 
surrounding nephrogenic mesenchyme (Sonnenberg et al., 
1993).  Our present data suggest that the paracrine effects of 
SF/HGF in vivo leading to changes in cell motility, migra- 
tion,  differentiation, and proliferation,  are  also  mediated 
through the protooncogene product c-Met. 
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